N

NeuroSense Therapeutics Ltd
D

NRSN

1.19000
USD
-0.06
(-4.80%)
مغلق
حجم التداول
10,608
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
29,801,563
الأخبار المقالات

العنوان: NeuroSense Therapeutics Ltd

القطاع: Healthcare
الصناعة: Biotechnology
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.